1241 related articles for article (PubMed ID: 11011852)
1. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
3. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
Clarke R
Indian Heart J; 2000; 52(7 Suppl):S59-64. PubMed ID: 11339443
[TBL] [Abstract][Full Text] [Related]
4. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
Clarke R; Collins R
J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
[No Abstract] [Full Text] [Related]
5. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
7. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
9. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
B-Vitamin Treatment Trialists' Collaboration
Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
16. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
[TBL] [Abstract][Full Text] [Related]
17. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
18. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of homocysteine lowering and cognitive performance.
McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM
N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413
[TBL] [Abstract][Full Text] [Related]
20. Folate therapy and in-stent restenosis after coronary stenting.
Lange H; Suryapranata H; De Luca G; Börner C; Dille J; Kallmayer K; Pasalary MN; Scherer E; Dambrink JH
N Engl J Med; 2004 Jun; 350(26):2673-81. PubMed ID: 15215483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]